Level B and C in vivo/in vitro correlations: Statistical considerations

International Journal of Pharmaceutics

Volumn 158, Issue 2, 1997, Pages 185-193

  Cutler, David J ^a,b   Beyssac, Eric ^a   Aiache, Jean Marc ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

In vitro in vivo correlation; Statistics; Therapeutic range

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; BIOEQUIVALENCE; DISSOLUTION; DRUG FORMULATION; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; QUALITY CONTROL; STATISTICAL MODEL;

EID: 0031453871     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00262-7     Document Type: Article

References (6)

1. Aiache J.-M., Sournac M., Ducroux P., Renoux R., Kantelip J.-P., Ducros M. Etude de la biodisponibilitie comparative de l'acide acetylsalicylique a partir de quatre formes galeniques, application des moments statistiques dans l'interpretation des resultats et l'establishment de correlations in vitro/in vivo. J. Pharm. Belgium. 43:1988;292-302.
2. Cardot J.M., Beyssac E. In vitro/in vivo correlations: scientific implications and standardisation. Eur. J. Drug Metab. Pharmacokinet. 18:1993;113-120.
3. Cutler, D.J., 1995. In vivo/in vitro correlations and statistics. In: Blume, H., Midha, K. (Eds.), Bio-international 2, Bioavailability, Bioequivalence and Pharmacokinetic Studies. Medpharm Scientific Press, Stuttgart, pp. 281-289.
4. Ritschel, W.A., 1986. Handbook of basic pharmacokinetics, 3rd ed. Drug Intelligence Publications, Hamilton, IL, p. 497.
5. Skelly J.P., Shiu G.F. In vitro/in vivo correlations in biopharmaceutics: scientific and regulatory implications. Eur. J. Drug Metab. Pharmacokinet. 18:1993;121-129.
6. United States Pharmacopeia, 1995. United States Pharmacopoeial Convention, Rockville MD, p. 1927.